New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
07:01 EDTCRMECardiome announces commercializatoin partnership for Aggrastat
Cardiome announced an agreement with AOP Orphan Pharmaceuticals AG, headquartered in Vienna, Austria, to commercialize Aggrastat in selected European markets. AOP Orphan will be responsible for the commercialization of Aggrastat in the AOP Orphan countries. Under terms of the agreement, AOP Orphan has agreed to specific annual commercial goals for Aggrastat. Financial details of the agreement were not disclosed.
News For CRME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 24, 2015
08:03 EDTCRMECardiome expands commercialization partnership with Eddingpharm
Cardiome announced that its subsidiary, Correvio International Sarl, has entered into an exclusive license and supply agreement with Eddingpharm to distribute and commercialize AGGRASTAT in China. Financial terms of the agreement include milestone payments and minimum annual commercial commitments. The financial terms of the agreement are not disclosed.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use